GEO Investing

We just published a bullish article our analyst wrote on a high conviction idea that’s in one of our model portfolios. The stock is also in our high performing infrastructure and data center screens. Even though the stock has risen by more than 60% over the past year, we believe we are still early. The stock hit a new all-time high after earnings, yet still currently trades at a 45% discount to its peer group on EV/EBITDA. We went deeper into why that gap should close.

Currently trading at a P/E of around 9.7x, we see clear room for this company to experience a re-rating due to growing earnings that are becoming more predictable. Public peers in this infrastructure industry typically trade at far higher valuations, often in the P/E of 15–20x range. Our target company has now significantly expanded its manufacturing footprint, positioned itself closer to key customer clusters, and cleaned up both its cost base and legal overhangs. 

This stock we are pitching today is dropping fast for the wrong reasons and now has a P/E of near 5x. This is despite being a growth company with the lowest risk it has had in years. However, we believe the P/E could eventually expand to over 20x, setting us up for a rare multibagger move of at least 300%.
Sometimes the best opportunities in microcap investing aren’t buried in futuristic tech or obscure biotech patents. Sometimes, they’re hiding in plain sight.

There’s a little-known company we’ve been tracking for a while now—a turnaround story that’s been quietly grinding through operational changes, product rollouts, and a broader reinvention of its brand identity. It’s not the kind of name you’ll hear pitched by even other microcap investors, but recent developments in a new supplement market it recently entered just made this stock a lot more interesting for investors who appreciate the power of information arbitrage.

In reaction to Trump’s tariff chaos on the market, investors are selling first and asking questions later. We want to profit from this irrational behavior.

What follows are the key product groups that are exempt from Trump’s last round of tariffs.

Our goal will be to find a few nanocap, microcap and and small cap stocks that operate in these categories, where their stock prices are getting hammered. AND that may actually benefit from these tariffs.

We have one under-the-radar stock in our Run to $1 Model Portfolio which stands to benefit significantly from President Trump’s policies aimed at reviving U.S. fossil fuel energy production and bolstering economic expansion.

Under previous administrations, many smaller companies within the fossil fuel energy sector were dismissed as obsolete. The lack of valuation expansion in some traditional energy stocks has been driven by unfavorable political sentiment, a lack of pro-growth initiatives, and investor neglect.

Decades of micro-cap research taught me that hidden details in press releases can reveal opportunities that result in outsized investment gains. To capitalize on this, my team and I developed a specialized platform that quickly prioritizes  smaller-cap public company press releases so we can identify and act on critical insights ahead of the crowd— Two recent multibagger case studies of stocks on our Model Portfolios showcase this advantage